Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+)ALL04

Incorporation of imatinib into chemotherapeutic regimens has improved the prognosis of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+)ALL). We investigated a role of imatinib immediately before hematopoietic stem cell transplantation (HSCT). Children with Ph(+)ALL...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Manabe, Atsushi, Kawasaki, Hirohide, Shimada, Hiroyuki, Kato, Itaru, Kodama, Yuichi, Sato, Atsushi, Matsumoto, Kimikazu, Kato, Keisuke, Yabe, Hiromasa, Kudo, Kazuko, Kato, Motohiro, Saito, Tomohiro, Saito, Akiko M, Tsurusawa, Masahito, Horibe, Keizo
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2015
Teme:
Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4430261/
https://ncbi.nlm.nih.gov/pubmed/25641907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.383
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items